![Assessing DCE-MRI and DWI as Treatment Response Biomarkers After SABR for Primary Renal Cell Carcinoma](http://www.ia-grp.com/wp-content/plugins/revslider/public/assets/assets/transparent.png)
![](http://www.ia-grp.com/wp-content/uploads/2017/07/ORANGE-SLIDER-SHAPE-1.1.png)
Assessing DCE-MRI and DWI as Treatment Response Biomarkers After SABR for Primary Renal Cell Carcinoma
Published:
April 18, 2018
Publication:
American Society of Clinical Oncology (ASCO)
Authors:
Hayley Reynolds, Bimal Parameswaran, Mary Finnegan, Diana Roettger, Eddie Lau, Tomas Kron, Mark Shaw, Sarat Chander, and Shankar Siva